University College London: Europe's First CAR T Cell Trial for Amyloidosis Opens
May 07, 2026
May 07, 2026
LONDON, England, May 7 -- The University College London posted the following news:
* * *
Europe's first CAR T cell trial for amyloidosis opens
Three patients with light chain amyloidosis have been treated with CAR T cell therapy in the first European clinical trial testing the safety and efficacy of this immunotherapy in this patient group, led by UCL and UCLH researchers.
The ALARIC trial, which was developed within the UK Myeloma Researc . . .
* * *
Europe's first CAR T cell trial for amyloidosis opens
Three patients with light chain amyloidosis have been treated with CAR T cell therapy in the first European clinical trial testing the safety and efficacy of this immunotherapy in this patient group, led by UCL and UCLH researchers.
The ALARIC trial, which was developed within the UK Myeloma Researc . . .